Source | Evidence on protein | Close homologs |
---|---|---|
Cuervo et al. | no | yes: 0 |
Hassani et al. | no | yes: 0 |
Forrest at al. (metacyclic) | no | yes: 0 |
Forrest at al. (procyclic) | no | yes: 0 |
Silverman et al. | no | yes: 0 |
Pissara et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Pires et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Silverman et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
Jamdhade et al. | no | yes: 0 |
Source | Evidence on protein | Close homologs |
---|---|---|
DeepLoc | ||
SignalP6 | no | yes: 0, no: 11 |
NetGPI | no | yes: 0, no: 11 |
Term | Name | Level | Count |
---|---|---|---|
GO:0005654 | nucleoplasm | 2 | 1 |
GO:0110165 | cellular anatomical entity | 1 | 1 |
Related structures:
AlphaFold database: E9ARE0
Term | Name | Level | Count |
---|---|---|---|
GO:0003676 | nucleic acid binding | 3 | 11 |
GO:0003723 | RNA binding | 4 | 10 |
GO:0005488 | binding | 1 | 11 |
GO:0097159 | organic cyclic compound binding | 2 | 11 |
GO:1901363 | heterocyclic compound binding | 2 | 11 |
Leishmania | From | To | Domain/Motif | Score |
---|---|---|---|---|
CLV_NRD_NRD_1 | 111 | 113 | PF00675 | 0.749 |
CLV_NRD_NRD_1 | 216 | 218 | PF00675 | 0.659 |
CLV_PCSK_KEX2_1 | 113 | 115 | PF00082 | 0.588 |
CLV_PCSK_KEX2_1 | 296 | 298 | PF00082 | 0.595 |
CLV_PCSK_PC1ET2_1 | 113 | 115 | PF00082 | 0.588 |
CLV_PCSK_PC1ET2_1 | 296 | 298 | PF00082 | 0.621 |
CLV_PCSK_SKI1_1 | 146 | 150 | PF00082 | 0.451 |
CLV_PCSK_SKI1_1 | 218 | 222 | PF00082 | 0.685 |
CLV_PCSK_SKI1_1 | 271 | 275 | PF00082 | 0.530 |
DOC_CYCLIN_yCln2_LP_2 | 126 | 129 | PF00134 | 0.623 |
DOC_MAPK_gen_1 | 112 | 123 | PF00069 | 0.626 |
DOC_MAPK_gen_1 | 71 | 79 | PF00069 | 0.476 |
DOC_PP1_RVXF_1 | 229 | 236 | PF00149 | 0.503 |
DOC_PP1_RVXF_1 | 36 | 42 | PF00149 | 0.581 |
DOC_PP2B_LxvP_1 | 126 | 129 | PF13499 | 0.623 |
DOC_PP4_MxPP_1 | 133 | 136 | PF00568 | 0.473 |
DOC_USP7_MATH_1 | 285 | 289 | PF00917 | 0.568 |
DOC_USP7_MATH_1 | 316 | 320 | PF00917 | 0.510 |
DOC_WD40_RPTOR_TOS_1 | 327 | 332 | PF00400 | 0.581 |
DOC_WW_Pin1_4 | 207 | 212 | PF00397 | 0.744 |
DOC_WW_Pin1_4 | 236 | 241 | PF00397 | 0.552 |
DOC_WW_Pin1_4 | 259 | 264 | PF00397 | 0.353 |
DOC_WW_Pin1_4 | 97 | 102 | PF00397 | 0.717 |
LIG_14-3-3_CanoR_1 | 315 | 321 | PF00244 | 0.516 |
LIG_APCC_ABBA_1 | 169 | 174 | PF00400 | 0.592 |
LIG_APCC_ABBA_1 | 8 | 13 | PF00400 | 0.344 |
LIG_Clathr_ClatBox_1 | 326 | 330 | PF01394 | 0.659 |
LIG_FHA_1 | 116 | 122 | PF00498 | 0.602 |
LIG_FHA_1 | 188 | 194 | PF00498 | 0.577 |
LIG_LIR_Apic_2 | 196 | 200 | PF02991 | 0.617 |
LIG_LIR_Gen_1 | 120 | 131 | PF02991 | 0.648 |
LIG_LIR_Gen_1 | 170 | 180 | PF02991 | 0.524 |
LIG_LIR_Gen_1 | 26 | 35 | PF02991 | 0.468 |
LIG_LIR_Nem_3 | 120 | 126 | PF02991 | 0.529 |
LIG_LIR_Nem_3 | 170 | 175 | PF02991 | 0.522 |
LIG_LIR_Nem_3 | 248 | 254 | PF02991 | 0.518 |
LIG_LIR_Nem_3 | 26 | 30 | PF02991 | 0.476 |
LIG_LIR_Nem_3 | 304 | 308 | PF02991 | 0.585 |
LIG_MYND_3 | 141 | 145 | PF01753 | 0.543 |
LIG_NRBOX | 188 | 194 | PF00104 | 0.524 |
LIG_PCNA_yPIPBox_3 | 159 | 172 | PF02747 | 0.456 |
LIG_PCNA_yPIPBox_3 | 334 | 343 | PF02747 | 0.610 |
LIG_SH2_GRB2like | 66 | 69 | PF00017 | 0.553 |
LIG_SH2_PTP2 | 9 | 12 | PF00017 | 0.449 |
LIG_SH2_SRC | 66 | 69 | PF00017 | 0.484 |
LIG_SH2_STAT5 | 140 | 143 | PF00017 | 0.610 |
LIG_SH2_STAT5 | 51 | 54 | PF00017 | 0.562 |
LIG_SH2_STAT5 | 66 | 69 | PF00017 | 0.418 |
LIG_SH2_STAT5 | 9 | 12 | PF00017 | 0.417 |
LIG_SUMO_SIM_par_1 | 241 | 249 | PF11976 | 0.542 |
LIG_SUMO_SIM_par_1 | 252 | 259 | PF11976 | 0.574 |
LIG_SUMO_SIM_par_1 | 75 | 81 | PF11976 | 0.615 |
LIG_TYR_ITIM | 7 | 12 | PF00017 | 0.515 |
MOD_CDK_SPxK_1 | 236 | 242 | PF00069 | 0.581 |
MOD_CK1_1 | 210 | 216 | PF00069 | 0.642 |
MOD_CK1_1 | 255 | 261 | PF00069 | 0.506 |
MOD_CK1_1 | 94 | 100 | PF00069 | 0.654 |
MOD_CK2_1 | 92 | 98 | PF00069 | 0.729 |
MOD_Cter_Amidation | 215 | 218 | PF01082 | 0.660 |
MOD_GlcNHglycan | 101 | 104 | PF01048 | 0.753 |
MOD_GlcNHglycan | 145 | 149 | PF01048 | 0.434 |
MOD_GlcNHglycan | 212 | 215 | PF01048 | 0.727 |
MOD_GlcNHglycan | 287 | 290 | PF01048 | 0.567 |
MOD_GlcNHglycan | 55 | 58 | PF01048 | 0.244 |
MOD_GSK3_1 | 144 | 151 | PF00069 | 0.641 |
MOD_GSK3_1 | 205 | 212 | PF00069 | 0.601 |
MOD_GSK3_1 | 255 | 262 | PF00069 | 0.463 |
MOD_GSK3_1 | 283 | 290 | PF00069 | 0.580 |
MOD_GSK3_1 | 87 | 94 | PF00069 | 0.661 |
MOD_NEK2_1 | 144 | 149 | PF00069 | 0.523 |
MOD_NEK2_1 | 175 | 180 | PF00069 | 0.475 |
MOD_NEK2_1 | 193 | 198 | PF00069 | 0.632 |
MOD_PIKK_1 | 187 | 193 | PF00454 | 0.574 |
MOD_PIKK_1 | 297 | 303 | PF00454 | 0.523 |
MOD_PIKK_1 | 87 | 93 | PF00454 | 0.694 |
MOD_PKA_2 | 115 | 121 | PF00069 | 0.612 |
MOD_PKA_2 | 216 | 222 | PF00069 | 0.627 |
MOD_PKB_1 | 114 | 122 | PF00069 | 0.579 |
MOD_Plk_1 | 144 | 150 | PF00069 | 0.446 |
MOD_Plk_4 | 304 | 310 | PF00069 | 0.526 |
MOD_ProDKin_1 | 207 | 213 | PF00069 | 0.745 |
MOD_ProDKin_1 | 236 | 242 | PF00069 | 0.551 |
MOD_ProDKin_1 | 259 | 265 | PF00069 | 0.341 |
MOD_ProDKin_1 | 97 | 103 | PF00069 | 0.716 |
MOD_SUMO_rev_2 | 298 | 308 | PF00179 | 0.361 |
MOD_SUMO_rev_2 | 33 | 39 | PF00179 | 0.477 |
TRG_ENDOCYTIC_2 | 51 | 54 | PF00928 | 0.569 |
TRG_ENDOCYTIC_2 | 9 | 12 | PF00928 | 0.449 |
TRG_NES_CRM1_1 | 167 | 181 | PF08389 | 0.589 |
TRG_NES_CRM1_1 | 26 | 40 | PF08389 | 0.562 |
TRG_NLS_MonoExtC_3 | 111 | 116 | PF00514 | 0.514 |
TRG_NLS_MonoExtN_4 | 109 | 116 | PF00514 | 0.527 |
TRG_Pf-PMV_PEXEL_1 | 166 | 170 | PF00026 | 0.505 |
Protein | Taxonomy | Sequence identity | Coverage |
---|---|---|---|
A0A0N1IJR6 | Leptomonas seymouri | 42% | 99% |
A0A1X0P7J4 | Trypanosomatidae | 28% | 96% |
A0A3S7WUR3 | Leishmania donovani | 88% | 100% |
A0A422NWM0 | Trypanosoma rangeli | 30% | 96% |
A4H9A9 | Leishmania braziliensis | 67% | 100% |
A4HXM9 | Leishmania infantum | 87% | 100% |
C9ZZY5 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
D0A069 | Trypanosoma brucei gambiense (strain MHOM/CI/86/DAL972) | 31% | 100% |
Q4QE39 | Leishmania major | 87% | 100% |
V5B9X5 | Trypanosoma cruzi | 31% | 99% |